Skip to Main Content

Paper Details

Rationale, Design and Baseline Characteristics of the PARAGLIDE-HF Trial: Sacubitril/Valsartan vs Valsartan in HFmrEF and HFpEF With a Worsening Heart Failure Event.
J Card Fail
6
2023
Author NameAffiliation
Adrian F HernandezDuke Clinical Research Institute
David A MorrowBrigham and Women's Hospital, Harvard Medical School
David A MorrowBrigham and Women's Hospital, Harvard Medical School
Eric J VelazquezYale School of Medicine
Eric J VelazquezYale School of Medicine
Eugene BraunwaldBrigham and Women's Hospital, Harvard Medical School
  • 1 - 6

Datasets

Release 1.2